Targeting CD38 to reduce anti-HLA antibody levels: A new and effective option to be integrated into desensitization protocols?
{{output}}
Desensitization protocols are employed in patients with antibody-mediated organ rejection or hematopoietic stem cell (HSC) transplant recipients from ´HLA-mismatched´ donors with donor-specific antibodies (DSA). However, these protocols sometimes have limita... ...
